Table 2 Repeated measures analysis of clinical and metabolic characteristic from baseline to year 1 and 3 in the Diabetes in Europe Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) project (n = 105)
Baseline | Change from baseline to year 1 | Change from baseline to year 3 | P value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Mean | SD | Mean | SD | Mean | SD | Baseline vs after 1 year | Baseline vs after 2 years | 1 year vs 3 years | Repeated measures all changes | |
Weight (kg) | 105 | 82,85 | 15,20 | −2,27 | 5,25 | −1,14 | 5,83 | 0,000 | 0,143 | 0,041 | 0,048 |
BMI (kg/m2) | 105 | 31,10 | 4,93 | −0,84 | 1,91 | −0,35 | 2,18 | 0,000 | 0,000 | 0,018 | 0,000 |
WC (cm) | 105 | 96,67 | 11,41 | −3,95 | 5,71 | −0,62 | 7,40 | 0,000 | 1,000 | 0,000 | 0,100 |
SBP (mmHg) | 105 | 130,72 | 14,09 | −1,97 | 15,58 | 0,11 | 16,50 | 0,593 | 1,000 | 0,472 | 0,313 |
DBP (mmHg) | 105 | 80,80 | 8,97 | −1,36 | 9,10 | −0,56 | 10,25 | 0,385 | 1,000 | 0,955 | 0,579 |
Fasting glucose (mmol/l) | 105 | 5,22 | 0,72 | 0,17 | 0,67 | 0,13 | 0,68 | 0,066 | 0,067 | 1,000 | 0,037 |
2-h OGTT glucose (mmol/l) | 105 | 5,78 | 1,75 | 0,29 | 2,12 | 0,21 | 2,45 | 0,485 | 1,000 | 1,000 | 0,373 |
TCH ( mmol/l) | 105 | 5,55 | 0,94 | −0,26 | 1,16 | −0,29 | 1,03 | 0,065 | 0,016 | 1,000 | 0,013 |
HDL ( mmol/l) | 105 | 1,39 | 0,35 | −0,05 | 0,28 | −0,05 | 0,54 | 0,027 | 0,053 | 1,000 | 0,352 |
TG ( mmol/l) | 105 | 1,77 | 1,38 | −0,14 | 1,33 | −0,23 | 1,23 | 0,130 | 0,120 | 0,560 | 0,061 |
FINDRISK | 105 | 18,57 | 3,09 | −2,81 | 3,64 | −2,27 | 4,28 | 0,000 | 0,000 | 0,503 | 0,000 |